Clostridium difficileinfection (CDI) is a leading cause of hospital-associated gastrointestinal
illness and places a high burden on our health-care system. Patients with CDI typically have …

Clostridium difficile is the leading identified cause of nosocomial diarrhea associated with
antibiotic therapy. About 3% to 29% of hospitalized patients who receive antibiotics develop …

Since publication of the Society for Healthcare Epidemiology of America position paper on
Clostridium difficile infection in 1995, significant changes have occurred in the epidemiology …

The epidemiology of Clostridium difficile infection (CDI) has changed over the past decade.
There has been a dramatic worldwide increase in its incidence, and new CDI populations …

Clostridium difficile is a gram-positive anaerobic bacillus responsible for approximately 1 of
5 cases of antibiotic-associated diarrhea. C difficile infection (CDI) is defined by at least 3 …

Clostridium difficile infection (CDI) is increasingly common, and it is associated with
significant morbidity, mortality, and cost burden for patients and the healthcare system. The …

Clostridium difficile was first described as a cause of diarrhea in 1978 and in the last three
decades has reached an epidemic state with increasing incidence and severity in both …

Clostridium difficile infection (CDI) is increasing in frequency and severity in and out of the
hospital, with a high probability of recurrence after treatment. The recent literature on CDI …

Clostridium difficile is the most frequently identified cause of nosocomial diarrhea and has
been associated with epidemics of diarrhea in hospitals and long-term care facilities. The …

There has been dramatic change in the epidemiology of Clostridium difficile infection (CDI)
since the turn of the 21st century noted by a marked increase in incidence and severity …